Los Angeles Capital Management’s Kymera Therapeutics KYMR Stock Holding History

Los Angeles Capital Management’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$542K	Hold	4,730	–	–	﹤0.01%	894
2026 Q1	$394K	Buy	4,730 +2,762	+140%	+$219K	﹤0.01%	947
2025 Q4	$121K	Buy	+1,968	New	+$133K	﹤0.01%	1370
2024 Q2	–	Sell	-5,911	Closed	-$238K	–	1233
2024 Q1	$238K	Sell	5,911 -3,737	-39%	-$134K	﹤0.01%	1069
2023 Q4	$246K	Buy	+9,648	New	+$173K	﹤0.01%	1063
2023 Q3	–	Sell	-9,648	Closed	-$222K	–	1183
2023 Q2	$222K	Buy	+9,648	New	+$276K	﹤0.01%	1098

Other funds holding KYMR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Los Angeles Capital Management's KYMR Position: Q2 2026 in Review

Los Angeles Capital Management held its Kymera Therapeutics (KYMR) position steady in Q2 2026 at 4,730 shares worth $542K. The position accounts for ﹤0.01% of the portfolio, ranked #894.

Los Angeles Capital Management first reported a position in KYMR in Q2 2023 and has held it in 6 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

Los Angeles Capital Management held 4,730 shares of Kymera Therapeutics worth $542K as of Q2 2026.
Los Angeles Capital Management left its Kymera Therapeutics share count unchanged in Q2 2026.
Kymera Therapeutics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #894 holding.
Los Angeles Capital Management first reported a position in Kymera Therapeutics in Q2 2023 and has held it in 6 quarters since.
276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.